Real-world Clinical Outcomes in Non-metastatic (M0) Castration-Resistant Prostate Cancer (CRPC) Patients in Australia

被引：0
|
作者：
Gupta, Karan [1 ]
Goh, Jeffrey [1 ]
Gan, Chun [1 ]
Anton, Arsha [2 ,3 ]
Weickhard, Andrew
Azad, Arun
Uccellini, Anthony
Brown, Stephen
Wong, Shirley
Parente, Phillip [2 ]
Shapiro, Julia
Liow, Elizabeth
Torres, Javier [2 ,4 ]
Parnis, Francis [5 ]
Steer, Christopher [6 ]
Warren, Mark
Gibbs, Peter [3 ]
Tran, Ben [7 ]
机构：
[1] ANZUP, Camperdown, NSW, Australia
[2] Monash Univ, Melbourne, Vic, Australia
[3] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia
[4] Univ Melbourne, Rural Med Sch, Melbourne, Vic, Australia
[5] Univ Adelaide, Adelaide, SA, Australia
[6] Univ NSW, Rural Clin Campus, Albury, NSW, Australia
[7] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
abs67
引用
收藏
页码：93 / 94
页数：2
相关论文
共 50 条
  • [1] Clinical characteristics and outcomes for patients with non-metastatic castration-resistant prostate cancer
    Arnold, Peter
    Penaloza-Ramos, Maria Cristina
    Adedokun, Lola
    Rees, Sarah
    Lockhat, Mohamed
    Spary, Lisa
    Watkins, Alan
    Gnanapragasam, Vincent
    Crabb, Simon J.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [2] International prevalence of nonmetastatic (M0) castration-resistant prostate cancer (CRPC).
    Liede, Alexander
    Arellano, Jorge
    Hechmati, Guy
    Bennett, Brian
    Wong, Steven
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] REAL-WORLD EFFECTIVENESS AND TREATMENT ADHERENCE OF APALUTAMIDE IN NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS
    Lowentritt, Benjamin
    Brown, Gordon
    Kernen, Kenneth
    Pilon, Dominic
    Ellis, Lorie
    Germain, Guillaume
    Rossi, Carmine
    Lefebvre, Patrick
    Sieber, Paul
    Shore, Neal
    JOURNAL OF UROLOGY, 2021, 206 : E58 - E58
  • [4] Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate Cancer
    Madan, Ravi A.
    Bilusic, Marijo
    Stein, Mark N.
    Donahue, Renee N.
    Arlen, Philip M.
    Karzai, Fatima
    Plimack, Elizabeth
    Wong, Yu-Ning
    Geynisman, Daniel M.
    Zibelman, Matthew
    Mayer, Tina
    Strauss, Julius
    Chen, Gang
    Rauckhorst, Myrna
    McMahon, Sheri
    Couvillon, Anna
    Steinberg, Seth
    Figg, William D.
    Dahut, William L.
    Schlom, Jeffrey
    Gulley, James L.
    ONCOLOGIST, 2023, 28 (07): : 642 - +
  • [5] Retrospective cohort analysis of real-world clinical outcomes in nonmetastatic (M0) castration-resistant prostate cancer (CRPC) treated with novel androgen receptor pathway inhibitors (ARPI).
    Gagnon, Richard
    Alimohamed, Nimira S.
    Watson, Alexander
    Batuyong, Eugene
    Chow, Alyssa
    Lee-Ying, Richard M.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [6] Association between health-related quality of life (HRQoL) and clinical outcomes in non-metastatic castration-resistant prostate cancer (M0 CRPC): Results from the PROSPER study.
    Attard, Gerhardt
    Saad, Fred
    Tombal, Bertrand F.
    Hussain, Maha
    Sternberg, Cora N.
    Phung, De
    Naidoo, Shevani
    Modelska, Katharina
    Reisman, Arlene
    Ivanescu, Cristina
    Penson, David F.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [7] Real-world use of darolutamide, enzalutamide, and apalutamide for non-metastatic castration-resistant prostate cancer (DEAR).
    George, Daniel J.
    Khan, Nasreen
    Constantinovici, Niculae
    Khan, Javeed
    Chen, Guifang
    Xu, Julie
    Ortiz, Jorge A.
    Morgans, Alicia K.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [8] Characterization of pathway to non-metastatic (M0) castration-resistant prostate cancer (CRPC) and high risk of bone metastases according to treating physicians in 19 countries
    Hope, K.
    Graham, A.
    Arellano, J.
    Liede, A.
    Shahinian, V.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S710 - S711
  • [9] Real-World Prostate-Specific Antigen Response and Treatment Adherence of Apalutamide in Patients With Non-Metastatic Castration-Resistant Prostate Cancer
    Lowentritt, Benjamin
    Brown, Gordon
    Pilon, Dominic
    Ellis, Lorie
    Germain, Guillaume
    Rossi, Carmine
    Lefebvre, Patrick
    Kernen, Kenneth
    Sieber, Paul
    Shore, Neal
    UROLOGY, 2022, 166 : 182 - 188
  • [10] Darolutamide for non-metastatic, castration-resistant prostate cancer
    Burki, Talha
    LANCET ONCOLOGY, 2019, 20 (03): : E139 - E139
12345